Doravirine works as well as dolutegravir to suppress HIV viral load, study finds
|
If you're a Black, 34-year-old South African woman living
with HIV, antiretroviral (ARV) treatment options have likely been
limited to tenofovir ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...